Side-by-side comparison

JNJ vs BSX — Side-by-side comparison

JNJ screens cheaper on EV/FCF, JNJ has the higher ROIC, BSX has grown revenue faster over five years, and BSX has the cleaner balance sheet by net debt / EBITDA.

JNJ

Johnson & Johnson

Price

$234.34

Market cap

$372.9B

Day %

N/A

BSX

Boston Scientific

Price

$57.78

Market cap

$154.2B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


JNJ Target	Johnson & Johnson	$372.9B	21.2x	20.0x	21.8%	2.7%	20.9%	67.9%	N/A	N/A
BSX	Boston Scientific	$154.2B	29.8x	41.6x	11.9%	15.2%	18.2%	69.0%	-0.4x	N/A

JNJ implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

20.0x

FCF yield

5.3%

5Y rev CAGR

2.7%

BSX implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

41.6x

FCF yield

2.4%

5Y rev CAGR

15.2%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for JNJ.

Grade C

/ 100

Quality Scorecard

Build-time composite score for BSX.

Grade C

/ 100